N/A
Completed N=10
Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women
Blood Loss
Source: ClinicalTrials.gov NCT00614432 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Volume of Intraoperative Blood Loss — 91.5; 52.2 milliliters
Summary
The primary objective of this study is to compare blood loss resulting from surgical termination of pregnancy up to 12 weeks gestation between women who are anticoagulated to therapeutic levels and those who are not anticoagulated. This study is based on the hypothesis that anticoagulant therapy does not increase intraoperative blood loss in women receiving surgical abortions up to 12 weeks gestation.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Volume of Intraoperative Blood Loss |
91.5; 52.2 | — |
Eligibility Criteria
Inclusion Criteria
- Female seeking abortion services
- Less than or equal to 12 weeks gestation
- Age 18-50
- Willing and able to sign informed consent
- Use of Coumadin or LMW heparin (treatment group only)
Exclusion Criteria
- Unwilling or unable to sign informed consent
- Women taking daily aspirin or herbal therapies containing gingko biloba
- Women with a known history of a bleeding disorder such as von willebrand's disease
Data sourced from ClinicalTrials.gov (NCT00614432). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.